Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases.
about
Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma.2018 ESMO Sarcoma and GIST Symposium: 'take-home messages' in soft tissue sarcoma.Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016
P2860
Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases.
@en
Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases.
@nl
type
label
Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases.
@en
Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases.
@nl
prefLabel
Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases.
@en
Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases.
@nl
P2093
P2860
P50
P1433
P1476
Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases
@en
P2093
Andreas Rosenwald
Andrew Wotherspoon
Fabio Facchetti
Falko Fend
Lisa Rimsza
Stefania Pittaluga
Stefano Aldo Pileri
Stephan Dirnhofer
P2860
P2888
P304
P356
10.1007/S00428-017-2176-1
P577
2017-07-10T00:00:00Z